SCHEMBL2566201

SCHEMBL2566201

CN1CCc2ccc(NC(=O)[C@@H](CCCCC(=O)O)NC(=O)Oc3ccc(Cl)s3)cc2CC1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CCKBR P32239 1/20 0.40
SIRT2 Q8IXJ6 3/20 0.36
SIRT1 Q96EB6 3/20 0.36
SIRT5 Q9NXA8 6/20 0.36
F10 P00742 3/20 0.35
HDAC1 Q13547 4/20 0.35
ROCK2 O75116 1/20 0.35
HDAC4 P56524 2/20 0.35
HDAC3 O15379 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC10 Q969S8 1/20 0.34
HDAC11 Q96DB2 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
HDAC9 Q9UKV0 1/20 0.34
HDAC5 Q9UQL6 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2568293 0.97 CCKBR (0.40) CCKBRSIRT2SIRT1SIRT5F10
SCHEMBL2572469 0.91 CCKBR (0.39) CCKBRSIRT2SIRT1SIRT5F10
SCHEMBL2572104 0.91 CCKBR (0.38) CCKBRF10ROCK2
SCHEMBL2571752 0.90 SIRT2 (0.39) SIRT2SIRT1F10HDAC1HDAC4
SCHEMBL2567570 0.90 CCKBR (0.37) CCKBRF10ROCK2
SCHEMBL2567471 0.90 F10 (0.36) CCKBRSIRT2SIRT1F10ROCK2
SCHEMBL2572736 0.89 CCKBR (0.38) CCKBRF10ROCK2
SCHEMBL3382957 0.89 F10 (0.44) CCKBRF10ROCK2
SCHEMBL2566723 0.89 CCKBR (0.37) CCKBRF10ROCK2
SCHEMBL2573538 0.88 CCKBR (0.38) CCKBRF10ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1899330-B9 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT BOEHRINGER INGELHEIM INT (DE) 2011-11-09 EP disclosed
EP-1899330-B1 SUBSTITUTED GLYCINAMIDES HAVING AN ANTITHROMBOTIC AND FACTOR XA-INHIBITING EFFECT BOEHRINGER INGELHEIM INT (DE) 2010-11-24 EP disclosed